4.7 Article

Enhancing osteogenesis of adipose-derived mesenchymal stem cells using gold nanostructure/peptide-nanopatterned graphene oxide

期刊

出版社

ELSEVIER
DOI: 10.1016/j.colsurfb.2021.111807

关键词

Graphene oxide; RGD peptide; Nanopattern; Mesenchymal stem cell; Osteogenesis

资金

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF2019R1C1C1007633, NRF2019M3A9H2031820, NRF2019R1A4A1028700]

向作者/读者索取更多资源

Graphene derivatives show promise for stem-cell-based regenerative therapies, especially in bone regeneration. A graphene oxide-based hybrid platform was developed to guide the osteogenesis of human adipose-derived mesenchymal stem cells effectively. The GOHP exhibited efficiency comparable to high-quality CVD-grown graphene in inducing osteogenesis by upregulating specific genes.
Graphene derivatives are highly promising materials for use in stem-cell-based regenerative therapies, particularly for bone regeneration. Herein, we report a graphene oxide (GO)-based hybrid platform (GOHP) that is highly effective for guiding the osteogenesis of human adipose-derived mesenchymal stem cells (hAMSCs). A GOcoated indium tin oxide (ITO) substrate was electrochemically modified with Au nanostructures (GNSs), following which a cysteine-modified quadruple-branched arginine-glycine-aspartic acid was self-assembled on the ITO-GO-GNS hybrid via Au-S bonds. The synthesized GOHP, with the highest density of GNSs (deposition time of 120 s), exhibited the highest osteogenic differentiation efficiency based on the osteogenic marker expression level, osteocalcin expression, and osteoblastic mineralisation. Remarkably, although GO is known to be less efficient than the high-quality pure graphene synthesised via chemical vapour deposition (CVD), the fabricated GOHP exhibited an efficiency similar to that of CVD-grown graphene in guiding the osteogenesis of hAMSCs. The total RNA sequencing results revealed that CVD graphene and GOHP induced the osteogenesis of hAMSCs by upregulating the transcription factors related to direct osteogenesis, Wnt activation, and extracellular matrix deposition. Considering that GO is easy to produce, cost-effective, and biocompatible, the developed GOHP is highly promising for treating various diseases/disorders, including osteoporosis, rickets, and osteogenesis imperfecta.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据